ConductScience.org, home

Paper559669

Metronidazole: review of uses and toxicity.

Roe FJ. J Antimicrob Chemother, 1977. Cited by 111 papers, by iCite.

Cite this record

ConductScience Library. Metronidazole: review of uses and toxicity. Papers, record 559669. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/559669

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Metronidazole: review of uses and toxicity.
PubMed
Journal
J Antimicrob Chemother
PubMed
Year
1977
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
111
iCite
Relative citation ratio, by iCite
5.05
iCite
Revised in PubMed
2019-05-09
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Roe FJF J

Source PubMed

Download CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
MetronidazoleMajor topic
Amebiasis
Anaerobiosis
Animals
Bacterial Infections
Female
Giardiasis
Humans
Radiation-Sensitizing Agents
Trichomonas Vaginitis

Source PubMed

Download CSV of topics

Cited by26

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 111 citations.

PMIDTitleJournalYearIn PapersSource
39179514Novel Prodrug Strategies for the Treatment of Tuberculosis.Chem Asian J2024https://conductscience.org/library/papers/39179514PubMed
35782149An Unusual U2AF2 Inhibits Splicing and Attenuates the Virulence of the Human Protozoan Parasite Entamoeba histolytica.Front Cell Infect Microbiol2022https://conductscience.org/library/papers/35782149PubMed
35624678Insights into the Mechanisms of Lactobacillus acidophilus Activity against Entamoeba histolytica by Using Thiol Redox Proteomics.Antioxidants (Basel)2022https://conductscience.org/library/papers/35624678PubMed
35548465An Overview of Mucosa-Associated Protozoa: Challenges in Chemotherapy and Future Perspectives.Front Cell Infect Microbiol2022https://conductscience.org/library/papers/35548465PubMed
34439488Entamoeba histolytica Adaption to Auranofin: A Phenotypic and Multi-Omics Characterization.Antioxidants (Basel)2021https://conductscience.org/library/papers/34439488PubMed
33302377Lactoferrin and Its Derived Peptides: An Alternative for Combating Virulence Mechanisms Developed by Pathogens.Molecules2020https://conductscience.org/library/papers/33302377PubMed
32023994Microbiological Air Quality and Drug Resistance in Airborne Bacteria Isolated from a Waste Sorting Plant Located in Poland-A Case Study.Microorganisms2020https://conductscience.org/library/papers/32023994PubMed
30175074High-Throughput Screening of Entamoeba Identifies Compounds Which Target Both Life Cycle Stages and Which Are Effective Against Metronidazole Resistant Parasites.Front Cell Infect Microbiol2018https://conductscience.org/library/papers/30175074PubMed
29089593New antituberculous drugs derived from natural products: current perspectives and issues in antituberculous drug development.J Antibiot (Tokyo)2017https://conductscience.org/library/papers/29089593PubMed
28410582Metronidazole for the treatment of Tritrichomonas foetus in bulls.BMC Vet Res2017https://conductscience.org/library/papers/28410582PubMed
25229475Effect of oral administration of metronidazole or prednisolone on fecal microbiota in dogs.PLoS One2014https://conductscience.org/library/papers/25229475PubMed
21984744Comment on: Identification of antimicrobial activity among FDA-approved drugs for combating Mycobacterium abscessus and Mycobacterium chelonae.J Antimicrob Chemother2012https://conductscience.org/library/papers/21984744PubMed
21879846Nitroimidazoles for the treatment of TB: past, present and future.Future Med Chem2011https://conductscience.org/library/papers/21879846PubMed
19149517Vaccines and photodynamic therapies for oral microbial-related diseases.Curr Drug Metab2009https://conductscience.org/library/papers/19149517PubMed
8698362An in vitro metronidazole susceptibility test for trichomoniasis using the InPouch TV test.Genitourin Med1996https://conductscience.org/library/papers/8698362PubMed
7039761Metronidazole in a single dose for the treatment of trichomoniasis. Failure of a 1-g single dose.Br J Vener Dis1982https://conductscience.org/library/papers/7039761PubMed
6983379Metronidazole resistance of Trichomonas vaginalis as a cause of treatment failure in trichomoniasis--A case report.Br J Vener Dis1982https://conductscience.org/library/papers/6983379PubMed
6783642Metronidazole and the isolation of temperature-sensitive photosynthetic mutants in cyanobacteria.J Bioenerg Biomembr1980https://conductscience.org/library/papers/6783642PubMed
6340904Clinical pharmacokinetics of metronidazole.Clin Pharmacokinet1983https://conductscience.org/library/papers/6340904PubMed
3830698Mechanism of toxicity of nitro compounds used in the chemotherapy of trichomoniasis.Environ Health Perspect1985https://conductscience.org/library/papers/3830698PubMed

See all 26 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/559669

GET https://conductscience.org/api/papers/v1/559669/cited_by?page=2